Show Search Form
human indexable | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
published | |||||||||||||
registered interest | |||||||||||||
answer date | |||||||||||||
date | |||||||||||||
date tabled | |||||||||||||
ddp created | |||||||||||||
answering body |
|
||||||||||||
question status | Tabled | ||||||||||||
answering dept id | 17 | ||||||||||||
answering dept short name | Health and Social Care | ||||||||||||
answering dept sort name | Health and Social Care | ||||||||||||
ddp modified |
|
||||||||||||
hansard heading | Sickle Cell Diseases: Health Services | ||||||||||||
house id | 1 | ||||||||||||
identifier | 277138 | ||||||||||||
legislature |
|
||||||||||||
parliament number | 57 | ||||||||||||
question first answered |
|
||||||||||||
question text | To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 23 May 2019 to Question 256313, which services (a) NHS England, (b) clinical commissioning groups and (c) other public bodies commission for sickle cell disease patients with (i) stroke, (ii) chronic kidney disease, (iii) end-stage renal disease and (iv) pulmonary hypertension; and what the annual per capita cost is of providing each of those services. | ||||||||||||
session |
|
||||||||||||
session number | 1 | ||||||||||||
tabling member constituency | Kingston upon Hull North | ||||||||||||
tabling member printed |
|
||||||||||||
title | House of Commons Tabled Parliamentary Question 2017/19 277138 | ||||||||||||
type |
|
||||||||||||
uin | 277138 | ||||||||||||
version | 1 | ||||||||||||
written parliamentary question type | NamedDay | ||||||||||||
answer |
|
||||||||||||
creator |
|
||||||||||||
publisher | 25259 | ||||||||||||
tabling member |
|